Amelenodor is under clinical development by AbbVie and currently in Phase I for Crohn's Disease (Regional Enteritis).

RS-1805 is under clinical development by Reistone Biopharma and currently in Phase I for Crohn's Disease (Regional Enteritis).

Early treatment of pediatric Crohn's disease with anti-tumor necrosis factor medications can substantially reduce the risk of ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

Vedolizumab prevented the postoperative recurrence of Crohn’s disease and should be considered a prophylactic treatment in ...

A recent study conducted on medical students by Peruvian researchers found that there may be a link between a chronic ...

A new study published recently in the journal Gut shows children with Crohn's who were prescribed anti-TNF (tumor necrosis ...

A new quick-and-easy nasal swab test for kids can diagnose the specific immune system drivers behind their asthma, ...

Intestinal ultrasound (IU) can be considered a screening tool for pediatric inflammatory bowel disease (IBD), according to a ...

In Kids with Crohn's Disease, TNF Inhibitors Help Prevent Serious Complications, Data Suggests By Dennis Thompson HealthDay Reporter FRIDAY, Dec. 27, 2024 (HealthDay News) A specific class of anti ...